Better access to treatment for patients, or clear rules for the approval of new medicines brings about a new drug reform, which the members of the National Council of the Slovak Republic have moved to second reading. The amendment to the Act on the scope and conditions for reimbursement of medicinal products, medical devices and dietetic foods introduces patients' entitlement to medicinal products for derogation, increases the availability of innovative medical devices, tailor-made medical devices and dietetic foods while at the same time strengthening control over the trade in medicinal products and forgery of prescriptions.
Health Minister Kamil Šaško stressed that this draft law is behind the whole sector and is the result of countless discussions and compromises. The debate on the drug law, which I consider to be one of the key in the field of health, has shown that this Parliament is also able to conduct the correct and constructive debate that the whole sector has followed. I am pleased that no one voted against in the vote on the move to second reading. That's the first important signal. said the Minister for Health. He stressed that any possible changes would be discussed at the level of the Health Ministry round table with representatives of patients, doctors and the entire health sector.The new drug legislation brings the following seven key changes:
1.We are introducing clear rules for the approval of new medicines, setting clear procedural deadlines and conditions for the market entry of medicines, medical devices and dietetics, as well as transparent information on them.
2. More new medicines and easier access to medicines for children and patients with severe diseases.

3. We introduce a patient's entitlement to medicines for exemption and clear rules on how to get medicines, including health insurance obligations

4.We facilitate the entry of innovative medical devices and dietetic foods with balanced nutritional composition will also be covered.

5. We ensure the availability and retention of medicines on the Slovak market, on which patients are dependent.

6. Fight against reexport - we strengthen control of drug trafficking and forgery of recipes so that medicines intended for Slovak patients remain in Slovakia.

7.We introduce the concept of treatment certainty - the patient must not remain without his treatment - the registration holder will have an obligation to treat patients.

Národná rada SR posunula novú liekovú legislatívu do druhého čítaniaNárodná rada SR posunula novú liekovú legislatívu do druhého čítania